Second-line sunitinib as a feasible approach for iodine-refractory differentiated thyroid cancer after the failure of first-line sorafenib

Vincenzo Marotta, Carolina Di Somma, Manila Rubino, Concetta Sciammarella, Roberta Modica, Luigi Camera, Michela Del Prete, Francesca Marciello, Valeria Ramundo, Luisa Circelli, Pasqualina Buonomano, Annamaria Colao, Antongiulio Faggiano

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)854-858
Number of pages5
Issue number3
Publication statusPublished - Aug 27 2015

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this